BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35750346)

  • 1. Epidemiology of the first and second waves of COVID-19 pandemic in Djibouti and the vaccination strategy developed for the response.
    Elhakim M; Tourab SB; Salem F; Van De Weerdt R
    BMJ Glob Health; 2022 Jun; 7(Suppl 3):. PubMed ID: 35750346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 pandemic in Djibouti: Epidemiology and the response strategy followed to contain the virus during the first two months, 17 March to 16 May 2020.
    Elhakim M; Tourab SB; Zouiten A
    PLoS One; 2020; 15(12):e0243698. PubMed ID: 33351802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Salyer SJ; Maeda J; Sembuche S; Kebede Y; Tshangela A; Moussif M; Ihekweazu C; Mayet N; Abate E; Ouma AO; Nkengasong J
    Lancet; 2021 Apr; 397(10281):1265-1275. PubMed ID: 33773118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination.
    Martín-Sánchez V; Ruiz-Garcia A; Vitelli-Storelli F; Serrano-Cumplido A; Barquilla-Garcia A; Micó-Pérez RM; Olmo-Quintana V; Calderón-Montero A; Segura-Fragoso A
    Semergen; 2023 Oct; 49(7):102026. PubMed ID: 37356278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second wave of COVID-19 in Nigeria: Lessons from the first wave.
    Okereke M; Fortune E; Peter AO; Ukor NA; Lucero-Prisno DE
    Int J Health Plann Manage; 2022 Mar; 37(2):650-656. PubMed ID: 34859489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions.
    Fan G; Yang Z; Lin Q; Zhao S; Yang L; He D
    Transbound Emerg Dis; 2021 Mar; 68(2):213-215. PubMed ID: 32892500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological comparison of the first and second waves of the COVID-19 pandemic in Nigeria, February 2020-April 2021.
    Akande OW; Elimian KO; Igumbor E; Dunkwu L; Kaduru C; Olopha OO; Ohanu DO; Nwozor L; Agogo E; Aruna O; Balogun MS; Aderinola O; Ahumibe A; Arinze C; Badaru SO; Nwachukwu W; Dada AO; Erameh C; Hamza K; Mohammed TB; Ndodo N; Obiekea C; Ofoegbunam C; Ogunbode O; Ohonsi C; Tobin EA; Yashe R; Adekaiyaoja A; Asuzu MC; Audu RA; Bello MB; Bello SO; Deeni YY; Disu Y; Joseph G; Ezeokafor C; Habib ZG; Ibeh C; Ike IF; Iwara E; Luka-Lawal RK; Namara G; Okwor T; Olajide L; Ilesanmi OO; Omonigho S; Oyiri F; Takpa K; Ugbogulu NU; Ibekwe P; Oladejo J; Ilori E; Ochu CL; Ihekweazu C
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34794956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pattern of COVID-19 in Horn of Africa countries, from March-December 2020.
    Ghebremichael ST; Tewolde RH; Andegiorgish AK; Pan G
    Afr Health Sci; 2023 Mar; 23(1):108-119. PubMed ID: 37545935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of increased mobility on SARS-CoV-2 transmission: a descriptive study of the trends of COVID-19 in Zimbabwe between December 2020 and January 2021.
    Murewanhema G; Burukai TV; Chiwaka L; Maunganidze F; Munodawafa D; Pote W; Mufunda J
    Pan Afr Med J; 2021; 39():125. PubMed ID: 34527141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The landscape of the COVID-19 pandemic in Poland emerging from epidemiological and genomic data.
    Mirska B; Zenczak M; Nowis K; Stolarek I; Podkowiński J; Rakoczy M; Marcinkowska-Swojak M; Koralewska N; Zmora P; Lenartowicz Onyekaa E; Osuch M; Łasińska K; Kuczma-Napierała J; Jaworska M; Madej Ł; Ciechomska M; Jamsheer A; Kurowski K; Figlerowicz M; Handschuh L
    Sci Rep; 2024 Jun; 14(1):14416. PubMed ID: 38909091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covid-19: temporal evolution and immunization in the three epidemiological waves, Brazil, 2020-2022.
    Moura EC; Cortez-Escalante J; Cavalcante FV; Barreto ICHC; Sanchez MN; Santos LMP
    Rev Saude Publica; 2022; 56():105. PubMed ID: 36515307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020-January 2022.
    Otshudiema JO; Folefack GLT; Nsio JM; Mbala-Kingebeni P; Kakema CH; Kosianza JB; Mfumu AK; Saidi GN; Kabongo PM; Okum R; Tshimbombu TN; Ahuka-Mundeke S; Karamagi HC; Muyembe JT; Djiguimde AP
    J Epidemiol Glob Health; 2022 Sep; 12(3):316-327. PubMed ID: 35921045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of COVID-19 and case fatality rate in Pune, India: an analysis of the first and second wave of the pandemic.
    Bogam P; Joshi A; Nagarkar S; Jain D; Gupte N; Shashidhara LS; Monteiro JM; Mave V
    IJID Reg; 2022 Mar; 2():74-81. PubMed ID: 35721428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional geographies and public health lessons of the COVID-19 pandemic in the Arctic.
    Tiwari S; Petrov AN; Golosov N; Devlin M; Welford M; DeGroote J; Degai T; Ksenofontov S
    Front Public Health; 2023; 11():1324105. PubMed ID: 38259778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first 30 days of COVID-19 vaccination in Cameroon: achievements, challenges, and lessons learned.
    Amani A; Djossaya D; Njoh AA; Fouda AAB; Ndoula S; Abba-Kabir HM; Mossus T; Nguefack-Tsague G; Kamgno J
    Pan Afr Med J; 2022; 41():201. PubMed ID: 35685114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of COVID-19 at nursing homes from the second wave to vaccination. Description of a coordination program between Primary Care, Geriatrics and Public Health.].
    Menéndez Colino R; Merello de Miguel A; Argentina F; Barcons Marqués M; Chaparro Jiménez B; López Hernández P; Jiménez Bueno S; Montero Vega MD; García Rodríguez J; Ferrer Simo B; Navarro Fernández MÁ; Rincón Del Toro T; Alarcón Alarcón T; Martínez Peromingo FJ; González-Montalvo JI
    Rev Esp Salud Publica; 2021 May; 95():. PubMed ID: 33973566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of COVID-19 situation between lower-middle-income countries in the eastern Mediterranean region.
    El Khamlichi S; Maurady A; Sedqui A
    J Oral Biol Craniofac Res; 2022; 12(1):165-176. PubMed ID: 34660189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting our vulnerable in the midst of the COVID-19 pandemic: lessons learnt from Malta.
    Cuschieri S; Grech V
    Public Health; 2021 Sep; 198():270-272. PubMed ID: 34492507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case for Cross-Border Governance? A Comparative Trend Assessment of COVID-19 Transmission, Vaccination, and Outcomes Among 35 Nations in Europe Across 18 months.
    Cuschieri S; Cuschieri A; Farrugia E; Diacono E; Balzan E; Grupetta M; Vella A; Cutajar C; Formosa M; Barbara M; Mintoff F; Shaw C; Fleri-Soler S; Borg N; Pace G; Vella L; Pisani R; Attard-Mallia T; Gouder M; Attard R; Grixti N; Scicluna M; Borda T; Bartolo K; Chircop R; Degabrielle-Ferrante E; Mallia M; Attard M; Frendo N; Gatt G; Damato G; Riolo N; Muscat-Baron L; Galea M; Grech E
    Disaster Med Public Health Prep; 2022 May; 17():e196. PubMed ID: 35492012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.